Pluristem Therapeutics, Inc. (PSTI) - NASDAQ
From other sites
Company Description
Pluristem Therapeutics, Inc. engages in the development of standardized cell therapy products for the treatment of life threatening diseases. Its patented PLX (PLacental eXpanded) cells drug delivery platform releases a cocktail of therapeutic proteins in response to a variety of local and... More
Sector: Healthcare
Industry: Biotechnology
Country: United States